FundedIQ
Biotechnology

Ocelot Bio: Funding, Investors & Team (Sep 2026)

Ocelot Bio brings new treatment options to patients with severe liver disease. The company was founded in 2020 and is headquartered in San Diego, California.

www.ocelotbio.com LinkedIn San Diego, United States 11-50 employees
Total raised
$39.0M
Rounds
2
Latest
Undisclosed round
Jul 2023

Ocelot Bio has raised $39.0M across 2 funding rounds on record, the most recent an undisclosed round of $3.0M announced in Jul 2023.

That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Ocelot Bio Company Profile and Key Stats

Total funding raised
$39.0M
across 2 rounds on record
Funding rounds on record
2
Latest funding round
Undisclosed round
$3.0M in Jul 2023
Employees
11-50
reported band
Headquarters
San Diego, United States

Latest funding round on record: Jul 2023.

Ocelot Bio Funding Rounds

Date
Round
Amount
Undisclosed round
$3.0M
Series A
$36.0M

Ocelot Bio raised $36.0M in a Series A announced in Mar 2022.

1.3 years later, an undisclosed round of $3.0M was announced in Jul 2023.

Ocelot Bio Founders and Leadership Team

Name
Role
Contact
Geoff Harris
CEO
Locked
Katherine Vega Stultz
CEO
Locked

Contact details for the Ocelot Bio team: 2 of 2 have an email address on file.

Start 14-day free trial →

Ocelot Bio Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,182
$8.0M
29,795
$7.5M

Ocelot Bio's latest round of $3.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Ocelot Bio in Biotechnology and San Diego

Companies Similar to Ocelot Bio

Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…

Series B $65.5M

Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…

Seed $7.0M

ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…

Series C $10.0M

EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…

Series A $35.0M

Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…

Convertible Note $3.5M

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…

Seed $3.1M

Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…

Series D $66.0M

Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…

Series B $92.7M

Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…

Series C $110M

InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…

Series B $77.0M

Ocelot Bio Funding FAQs

What does Ocelot Bio do?

Ocelot Bio brings new treatment options to patients with severe liver disease. The company was founded in 2020 and is headquartered in San Diego, California.

How much funding has Ocelot Bio raised?

Ocelot Bio has raised $39.0M across 2 rounds on record. The most recent is an undisclosed round of $3.0M announced in Jul 2023.

When did Ocelot Bio last raise funding?

Ocelot Bio's most recent funding round on record is an undisclosed round of $3.0M, announced in Jul 2023.

Who is the CEO of Ocelot Bio?

Geoff Harris is listed as CEO at Ocelot Bio.

Where is Ocelot Bio headquartered?

Ocelot Bio is based in San Diego, California, United States.

How many employees does Ocelot Bio have?

Ocelot Bio is in the 11-50 employee band.

How does Ocelot Bio's funding compare to other Biotechnology startups?

Ocelot Bio's latest round of $3.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.

About FundedIQ's Ocelot Bio Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Ocelot Bio is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.